GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neutra Corp (OTCPK:NTRR) » Definitions » EBIT

NTRR (Neutra) EBIT : $-0.17 Mil (TTM As of Apr. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Neutra EBIT?

Neutra's earnings before interest and taxes (EBIT) for the three months ended in Apr. 2024 was $-0.02 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Apr. 2024 was $-0.17 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Neutra's annualized ROC % for the quarter that ended in Apr. 2024 was -109.09%. Neutra's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2024 was -6,000.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Neutra's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2024 was -43.72%.


Neutra EBIT Historical Data

The historical data trend for Neutra's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neutra EBIT Chart

Neutra Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.36 -0.42 -0.57 -0.50 -0.23

Neutra Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.07 -0.05 -0.03 -0.02

Competitive Comparison of Neutra's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Neutra's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neutra's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neutra's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Neutra's EV-to-EBIT falls into.



Neutra EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neutra  (OTCPK:NTRR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Neutra's annualized ROC % for the quarter that ended in Apr. 2024 is calculated as:

ROC % (Q: Apr. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jan. 2024 ) + Invested Capital (Q: Apr. 2024 ))/ count )
=-0.06 * ( 1 - 0% )/( (0.056 + 0.054)/ 2 )
=-0.06/0.055
=-109.09 %

where

Note: The Operating Income data used here is four times the quarterly (Apr. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Neutra's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Apr. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jan. 2024  Q: Apr. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.06/( ( (0.001 + max(-0.92, 0)) + (0 + max(-0.933, 0)) )/ 1 )
=-0.06/( ( 0.001 + 0 )/ 1 )
=-0.06/0.001
=-6,000.00 %

where Working Capital is:

Working Capital(Q: Jan. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.919 + 0 + 0.00099999999999989)
=-0.92

Working Capital(Q: Apr. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.933 + 0 + -1.1102230246252E-16)
=-0.933

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Apr. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Neutra's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Apr. 2024 )
=-0.174/0.398
=-43.72 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neutra EBIT Related Terms

Thank you for viewing the detailed overview of Neutra's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Neutra Business Description

Traded in Other Exchanges
N/A
Address
2500 CityWest Boulevard, Suite 150-161, Houston, TX, USA, 77042
Neutra Corp is a research and development company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. It sells hemp-derived products, including products containing delta-8-THC and other cannabinoids. Geographically, all the activities are operated through the region of the United States.
Executives
Sydney Jim director, officer: CEO & Chairman 8875 HIDDEN RIVER PARKWAY, SUITE 300, TAMPA FL 34243